These results are consistent with our previous findings, which demonstrated that Epo appears to be a chemosensitizer and showed a synergistic antiproliferative effect with LFM-A13 in two colon cancer cells DLD-1 and HT-29.23 Here, EPO is linked to malignant colon neoplasm.